News
-
TEACHHing service providers how to best care for trans people
March 31 marks the International Transgender Day of Visibility, an annual event dedicated to celebrating transgender (trans) people…
-
Postdoc Spotlight: Dr. Adria Quigley
As a physical therapist, Dr. Adria Quigley has always been fascinated by how the brain works. Learn about…
-
Postdoc Spotlight: Dr. Elizabeth King
Dr. Elizabeth King is an infectious disease specialist who joined the CTN as a Postdoctoral Fellow in July…
-
New research comparing HIV medications set to change international recommendations
The WHO-funded study shows that dolutegravir is the optimal choice for first-line treatment of HIV
-
Examining the results of CTN 297: Black PRAISE
The Black PRAISE team have pioneered a novel intervention aimed at reducing HIV-related stigma while strengthening the HIV…
Resources
Our Resource Library is a place to share documents, videos, and training resources about HIV and STBBI research and related topics.
There are no results message
Studies
The CTN+ supports clinical trials, implementation science projects, and non-interventional research of the highest scientific and ethical standards.
-
CTNPT 055: Testing Immunogenicity and Durability of Mpox Vaccination in People Living with HIV
Vaccines in a Time of Dual Pandemic: COVID-19 Vaccine in People with HIV
-
CTN 343: Project ReportNeedles.ca
Project ReportNeedles.ca: A rapid assessment and response system to map needle prevalence and implement harm reduction interventions in Regina, Saskatchewan
-
CTN 260: Raltegravir switch study
A randomized prospective open-label study of switching to raltegravir based antiretroviral therapy (ART) compared to maintaining ritonavir boosted protease inhibitor-based ART on liver fibrosis progression in HIV-HCV co-infected individuals
Publications
Our researchers and trainees have produced hundreds of peer-reviewed publications in a wide range of HIV- and STBBI-related areas.